Susceptibility to exacerbation in chronic obstructive pulmonary disease.
By John R. Hurst, Jorgen Vestbo, A. Anzueto, N. Locantore, H. Müllerová, R. Tal-Singer, B. Miller, D. Lomas, Alvar Agusti, W. Macnee and 4 more. New England Journal of Medicine, 2010
2,914 citations recorded by the source corpus.
Subfields: Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/94c5689ed46bd50ef0aafc11ec65608711de890e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Pulmonary and Respiratory Medicine
- D. Parums
- J. Wedzicha
- P. Calverley
- Jorgen Vestbo
- A. Anzueto
- Bartolome Celli
- R. Rodríguez-Roisín
- Alvar Agusti
Citations in the corpus
- Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality (2012, background): “Indeed, patients with no exacerbations in a year could be early in their disease course while patients with multiple exacerbations could have had the disease for a long time, making it likely that part of the apparent differences in phenotypes of patients with and without frequent exacerbations is d”
- Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary (2023, positive): “age, female sex, smoking, lower FEV 1 , cough, higher SGRQ score, and a previous history of cardiovascular disease.”
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017, background): “Gastroesophageal reflux is an independent risk factor for exacerbations and is associated with worse health status.(251,340,341) Page 43 of 74 AJRCCM Articles in Press.”
- Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, positive): “Тех, кто сообщает о двух или более обострениях ХОБЛ в год, час" то определяют как устойчивый во времени фенотип «па" циент с частыми обострениями» [132].”
- Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012, methodology): “%) were frequent exacerbators according to the definition of Hurst et al [19], an additional 61 (28”